![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Issels, Rolf D. 
ORCID: https://orcid.org/0000-0002-3494-6561; Böck, Stefan; Pelzer, Uwe; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Ghadjar, Pirus; Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264; Albertsmeier, Markus ORCID: https://orcid.org/0000-0002-5028-5062; Angele, Martin K.; Schmidt, Michael ORCID: https://orcid.org/0000-0001-5898-9323; Xu, Yujun ORCID: https://orcid.org/0000-0002-8487-7584; Bahra, Marcus; Pratschke, Johann; Schoenberg, Michael; Thasler, Wolfgang E.; Salat, Christoph; Stoetzer, Oliver J.; Knoefel, Wolfram T.; Graf, Dirk; Wessalowski, Rüdiger; Keitel-Anselmino, Verena; Koenigsrainer, Alfred; Bitzer, Michael ORCID: https://orcid.org/0000-0002-4463-8263; Zips, Daniel; Bamberg, Michael; Fietkau, Rainer; Ott, Oliver; Kawecki, Maciej ORCID: https://orcid.org/0000-0001-7858-6214; Wyrwicz, Lucjan; Rutkowski, Piotr; Rentsch, Markus; Ababei, Juliana; Reichardt, Peter; Rigamonti, Marco; Weber, Bernhard; Abdel-Rahman, Sultan; Tschoep–Lechner, Katharina; Jauch, Karl-Walter; Bruns, Christiane J.; Oettle, Helmut; Bergwelt-Baildon, Michael von; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Werner, Jens
(2023):
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.
In: European Journal of Cancer (EJC), Bd. 181: S. 155-165
ORCID: https://orcid.org/0000-0002-3494-6561; Böck, Stefan; Pelzer, Uwe; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Ghadjar, Pirus; Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264; Albertsmeier, Markus ORCID: https://orcid.org/0000-0002-5028-5062; Angele, Martin K.; Schmidt, Michael ORCID: https://orcid.org/0000-0001-5898-9323; Xu, Yujun ORCID: https://orcid.org/0000-0002-8487-7584; Bahra, Marcus; Pratschke, Johann; Schoenberg, Michael; Thasler, Wolfgang E.; Salat, Christoph; Stoetzer, Oliver J.; Knoefel, Wolfram T.; Graf, Dirk; Wessalowski, Rüdiger; Keitel-Anselmino, Verena; Koenigsrainer, Alfred; Bitzer, Michael ORCID: https://orcid.org/0000-0002-4463-8263; Zips, Daniel; Bamberg, Michael; Fietkau, Rainer; Ott, Oliver; Kawecki, Maciej ORCID: https://orcid.org/0000-0001-7858-6214; Wyrwicz, Lucjan; Rutkowski, Piotr; Rentsch, Markus; Ababei, Juliana; Reichardt, Peter; Rigamonti, Marco; Weber, Bernhard; Abdel-Rahman, Sultan; Tschoep–Lechner, Katharina; Jauch, Karl-Walter; Bruns, Christiane J.; Oettle, Helmut; Bergwelt-Baildon, Michael von; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321 und Werner, Jens
(2023):
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial.
In: European Journal of Cancer (EJC), Bd. 181: S. 155-165
Bielack, Stefan S.; Reichardt, Peter; Lindner, Lars H. und Hecker-Nolting, Stefanie
(2022):
Systemische Therapie von Osteosarkomen. Wege aus der prognostischen Stagnation?
In: Onkologie, Bd. 28, Nr. 7: S. 555-562
Hofheinz, Ralf-Dieter; Merx, Kirsten; Haag, Georg M.; Springfeld, Christoph; Ettrich, Thomas; Borchert, Kersten; Kretzschmar, Albrecht; Teschendorf, Christian; Siegler, Gabriele; Ebert, Matthias P.; Goekkurt, Eray; Mahlberg, Rolf; Homann, Nils; Pink, Daniel; Bechstein, Wolf; Reichardt, Peter; Flach, Hagen; Gaiser, Timo; Battmann, Achim; Oduncu, Fuat S.; Loose, Maria; Sookthai, Disorn; Pauligk, Claudia; Goetze, Thorsten O. und Al-Batran, Salah-Eddin
(2022):
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group.
In: Journal of Clinical Oncology, Bd. 40, Nr. 32: S. 3750-3762
Pink, Daniel; Andreou, Dimosthenis; Bauer, Sebastian; Brodowicz, Thomas; Kasper, Bernd; Reichardt, Peter; Richter, Stephan; Lindner, Lars H.; Szkandera, Joanna; Gruenwald, Viktor; Kebenko, Maxim; Kirchner, Marietta und Hohenberger, Peter
(2021):
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(R) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06).
In: Cancers, Bd. 13, Nr. 6, 1223
Joensuu, Heikki; Eriksson, Mikael; Hall, Kirsten Sundby; Reichardt, Annette; Hermes, Barbara; Schuette, Jochen; Cameron, Silke; Hohenberger, Peter; Jost, Philipp J.; Al-Batran, Salah-Eddin; Lindner, Lars H.; Bauer, Sebastian; Wardelmann, Eva; Nilsson, Bengt; Kallio, Raija; Jaakkola, Panu; Junnila, Jouni; Alvegard, Thor und Reichardt, Peter
(2020):
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.
In: Jama Oncology, Bd. 6, Nr. 8: S. 1241-1246
Schmoll, Hans-Joachim; Lindner, Lars H.; Reichardt, Peter; Heissner, Klaus; Kopp, Hans-Georg; Kessler, Torsten; Mayer-Steinacker, Regine; Ruessel, Joern; Egerer, Gerlinde; Crysandt, Martina; Kasper, Bernd; Niederwieser, Dietger; Kunitz, Annegret; Eigendorff, Ekkehard; Petersen, Iver; Steighardt, Jörg; Cygon, Franziska; Meinert, Fabian und Stein, Alexander
(2020):
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.
In: Jama Oncology, Bd. 7, Nr. 2: S. 255-262
Stenzinger, Albrecht; Tilburg, Cornelis M. van; Tabatabai, Ghazaleh; Laenger, Florian; Graf, Norbert; Griesinger, Frank; Heukamp, Lukas C.; Hummel, Michael; Klingebiel, Thomas; Hettmer, Simone; Vokuhl, Christian; Merkelbach-Bruse, Sabine; Overkamp, Friedrich; Reichardt, Peter; Scheer, Monika; Weichert, Wilko; Westphalen, C. Benedikt; Bokemeyer, Carsten; Ivanyi, Philipp; Loges, Sonja; Schirmacher, Peter; Woermann, Bernhard; Bielack, Stefan und Seufferlein, Thomas T. W.
(2020):
Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen.
In: Pathologe, Bd. 42, Nr. 1: S. 103-115
Reichardt, Peter; Schlemmer, Marcus; Delgado Perez, Juan R.; Papai, Zsuzsanna; Prausova, Jana; Melichar, Bohuslav; Fumagalli, Elena; Barone, Carlo; Bauer, Sebastian; Pustowka, Anette; Crippa, Stefania; Castellana, Ramon; Quiering, Claudia und Le Cesne, Axel
(2019):
Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.
In: Oncology Research and Treatment, Bd. 42, Nr. 12: S. 629-634
Issels, Rolf D.; Lindner, Lars H.; Verweij, Jaap; Wessalowski, Rüdiger; Reichardt, Peter; Wust, Peter; Ghadjar, Pirus; Hohenberger, Peter; Angele, Martin K.; Salat, Christoph; Vujaskovic, Zeljko; Daugaard, Soeren; Mella, Olav; Mansmann, Ulrich; Dürr, Hans Roland; Knösel, Thomas; Abdel-Rahman, Sultan; Schmidt, Michael; Hiddemann, Wolfgang; Jauch, Karl-Walter; Belka, Claus und Gronchi, Alessandro
(2018):
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.
In: JAMA Oncology, Bd. 4, Nr. 4: S. 483-492
Mühlberg, Fabian; Funk, Stephanie; Zange, Leonora; Knobelsdorff-Brenkenhoff, Florian von; Blaszczyk, Edyta; Schulz, Alexander; Ghani, Saeed; Reichardt, Annete; Reichardt, Peter und Schulz-Menger, Jeanette
(2018):
Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.
In: Esc Heart Failure, Bd. 5, Nr. 4: S. 620-629
Casali, Paolo G.; Zalcberg, John; Cesne, Axel le; Reichardt, Peter; Blay, Jean-Yves; Lindner, Lars H.; Judson, Ian R.; Schoffski, Patrick; Leyvraz, Serge; Italiano, Antoine; Grunwald, Viktor; Pousa, Antonio Lopez; Kotasek, Dusan; Sleijfer, Stefan; Kerst, Jan M.; Rutkowski, Piotr; Fumagalli, Elena; Hogendoorn, Pancras; Litiere, Saskia; Marreaud, Sandrine; Graaf, Winette van der; Gronchi, Alessandro und Verweij, Jaap
(2017):
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
In: Journal of Clinical Oncology, Bd. 35, Nr. 15: S. 1713-1720
Joensuu, Heikki; Wardelmann, Eva; Sihto, Harri; Eriksson, Mikael; Hall, Kirsten Sundby; Reichardt, Annette; Hartmann, Jörg T.; Pink, Daniel; Cameron, Silke; Hohenberger, Peter; Al-Batran, Salah-Eddin; Schlemmer, Marcus; Bauer, Sebastian; Nilsson, Bengt; Kallio, Raija; Junnila, Jouni; Vehtari, Aki und Reichardt, Peter
(2017):
Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib An Exploratory Analysis of a Randomized Clinical Trial.
In: Jama Oncology, Bd. 3, Nr. 5: S. 602-609
Joensuu, Heikki; Eriksson, Mikael; Hall, Kirsten Sundby; Reichardt, Annette; Hartmann, Jörg T.; Pink, Daniel; Ramadori, Giuliano; Hohenberger, Peter; Al-Batran, Salah-Eddin; Schlemmer, Marcus; Bauer, Sebastian; Wardelmann, Eva; Nilsson, Bengt; Sihto, Harri; Bono, Petri; Kallio, Raija; Junnila, Jouni; Alvegård, Thor und Reichardt, Peter
(2016):
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
In: Journal of Clinical Oncology, Bd. 34, Nr. 3:
244-U99